| Předmět: |
|
| Zdroj: |
Diabetes; 2015 Supplement, Vol. 64, pA300-A336, 37p, 49 Charts, 12 Graphs |
| Abstrakt: |
The article presents abstracts on medical topics, which include such studies as the effects of PBI-4050 orally active compound against pancreatic fibrosis in type 2 diabetes, the effects of the novel dual pancreatic and hepatic acting glucokinase activator, HMS5552 in type 2 diabetes mellitus (T2DM) patients, and the effects of the clinically differentiated glucokinase activator HMS5552 in T2DM patients. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
